Single Posttranslational Modifications in the Central Repeat Domains of Tau4 Impact its Aggregation and Tubulin Binding
Open Access
- 14 December 2018
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 58 (6) , 1616-1620
Abstract
A variety of methods have been employed to study the impact of posttranslational modifications on Tau protein function. Here, a semisynthesis strategy is described that enables selective modification within the central repeat domain of Tau4 (residues 291‐321), comprising a major interaction motive with tubulin as well as one of the key hexapeptides involved in Tau aggregation. This strategy has led to the preparation of four semisynthetic Tau variants with phosphoserine residues in different positions and one with a so far largely ignored carboxymethyllysine modification that results from a non‐enzymatic posttranslational modification (nPTM). The latter modification inhibits tubulin polymerization but exhibits an aggregation behavior very similar to unmodified Tau. In contrast, phosphorylated Tau variants exhibit similar binding to tubulin as unmodified Tau4 but show lower tendencies to aggregate.Keywords
Funding Information
- Vienna Science and Technology Fund (LS17-008)
This publication has 48 references indexed in Scilit:
- Biochemistry and Cell Biology of Tau Protein in Neurofibrillary DegenerationCold Spring Harbor Perspectives in Medicine, 2012
- The Alzheimer’s Disease Related Tau Protein as a New Target for Chemical Protein EngineeringChemistry – A European Journal, 2012
- A One‐Pot Three‐Segment Ligation Strategy for Protein Chemical SynthesisAngewandte Chemie International Edition, 2011
- A One-Pot Three-Segment Ligation Strategy for Protein Chemical SynthesisAngewandte Chemie, 2011
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- Post-translational modifications of tau protein in Alzheimer’s diseaseJournal of Neural Transmission, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.Brain Research Reviews, 2000
- Nε-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard ReactionBiochemistry, 1996
- Physical and chemical properties of purified tau factor and the role of tau in microtubule assemblyJournal of Molecular Biology, 1977